Jill Henrich
EVP, Chief Regulatory Officer · Atara Biotherapeutics, Inc.
- 2024
- Nov 20, 2024
- 1
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Jill Henrich files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- EcoR1 Capital, LLC - $4.74M in ATRA purchases and sales in the last 12 months
- Panacea Innovation Ltd - $3.65M in ATRA purchases and sales in the last 12 months
- Brian N. Cherry - $1000K in ATRA purchases and sales in the last 12 months
- Anhco Nguyen - $142K in ATRA purchases and sales in the last 12 months
- Yanina Grant-Huerta - $57K in ATRA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jill Henrich?
Jill Henrich is a corporate insider, tracked as EVP, Chief Regulatory Officer of Atara Biotherapeutics, Inc. (ATRA). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Jill Henrich last file a Form 4?
The only primary Form 4 on record is dated 20 November 2024.
Has Jill Henrich been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($11K) across all tracked filings.
